Herbert Virgin - Nov 30, 2021 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
EVP, Research & CSO
Signature
/s/ Howard Horn, Attorney-in-Fact
Stock symbol
VIR
Transactions as of
Nov 30, 2021
Transactions value $
-$727,059
Form type
4
Date filed
12/2/2021, 04:12 PM
Previous filing
Nov 18, 2021
Next filing
Dec 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Options Exercise $23.1K +15.1K +14.04% $1.53* 123K Nov 30, 2021 Direct
transaction VIR Common Stock Sale -$62.7K -1.38K -1.12% $45.60 121K Nov 30, 2021 Direct F1
transaction VIR Common Stock Sale -$688K -13.8K -11.32% $50.00 108K Nov 30, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Options Exercise $0 -15.1K -6.16% $0.00 231K Nov 30, 2021 Common Stock 15.1K $1.53 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021.
F2 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.